TrialFrontiers in immunology2025

Immune repertoire sequencing reveals differences in treatment response to camrelizumab plus platinum-based chemotherapy in advanced ESCC.

Xiaoling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.